The comparison of EGFR-TKI failure modes and subsequent management between exon 19 deletion and exon 21 L858R mutation in advanced non-small-cell lung cancer
Journal of Cancer, Volume 8, Issue 10, 2017, Pages 1865-1871.
19 DelEGFR-TKIL858RNSCLCclinical failure modeMore(1+)
Background: Advanced non-small-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion (19 Del) and exon 21 L858R mutation (L858R) might be distinct diseases. Therefore, it is necessary to take EGFR mutation subgroups into consideration for making choices of subsequent treatment after tyrosine kinase inhibit...More
Full Text (Upload PDF)
PPT (Upload PPT)